Moderna, Coca-Cola and Visa Shares Hit 52-Week Highs on Company News
Moderna, Coca-Cola and Visa shares reached fresh 52-week highs on Thursday, helped by target increases and a KFC beverage deal, Stocktwits reports.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
According to Stocktwits, shares of Moderna (MRNA), Coca-Cola (KO) and Visa (V) reached new 52-week highs on Thursday after positive company news. Goldman Sachs raised its Moderna target to $137 from $120 and kept a Neutral rating, and the stock rose more than 4% to $242.29, a four-year high. Investors are awaiting Phase 3 melanoma data for intismeran, due at the ESMO Congress on October 24.
Coca-Cola set a record at $94.10 after KFC's U.S. restaurants agreed to switch from PepsiCo drinks to Coca-Cola products, giving it access to thousands of locations. Visa climbed to an all-time high of $403.21 after BMO Capital Markets lifted its target to $425 from $405 with an Outperform rating, citing steady payment activity and growth in value-added services. Moderna gained over 4%, Visa 2% and Coca-Cola 0.2%.
why it matters
Stocktwits notes the three stocks have gained between 13% and 701% so far this year. Retail sentiment on Moderna turned bearish, while it stayed bullish on Coca-Cola and extremely bullish on Visa. The moves suggest investors are favoring companies with dependable cash generation and pricing power, while Moderna's further gains depend on upcoming clinical data.
tags
instruments
sources
- Why Did MRNA, KO, V Stocks Climb To 52-Week Highs Today? — stocktwits.com, 16 October 2026 at 03:18 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗